Skip to content
GLP-1 Desk
Menu
Dispatch #170

Cielo

Cielo is a compounded-GLP-1-only telehealth platform offering semaglutide and tirzepatide with no brand-name drugs and no TRT, hair, or mental-health add-ons — a focused, single-purpose alternative to…

Visit CieloAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
$149/mo (all doses, compounded)
Tirzepatide
$249/mo (all doses, compounded)
Coverage
Coverage not published
Brand-name
Yes

Weigh Cielo against the full ranked field on the best semaglutide providers board, or line it up against its closest alternatives. Or go one-on-one: Cielo vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency84/100
State access24/100
Molecule range79/100
Onboarding speed72/100
Support responsiveness77/100
Licensing & trust68/100

What the Desk likes

  • Among the lowest 3-month bundle prices in compounded GLP-1 ($115/mo semaglutide)
  • Single flat price across all doses simplifies titration planning
  • Corporate address (St. Petersburg, FL) and customer-service phone published

Where points come off

  • No LegitScript, NABP .pharmacy, or HIPAA badge on the home page
  • Pharmacy partner not named (only 'regulated FDA pharmacy partners')
  • State coverage list not published — can't verify all-50-state availability
  • Clinical care runs through MD Integrations, a shared third-party network used by many brands
  • No brand-name Wegovy or Zepbound option

The Desk's briefing — C

Best for: Readers who want flat-rate compounded GLP-1 at the lowest 3-month bundle prices.

Cielo ranks #170 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect Cielo's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Cielo's site. Not medical advice; see our disclosure.

← Back to The Desk